Dr. Mazza is Illuminating the Future of Thyroid Care with PBMT

Photobiomodulation as the First Disease-Modifying Therapy for Hashimoto Thyroiditis

By Dr. Angela Mazza, DO, ABAARM, FAAMFM, ECNU, CDE

---

Special thanks to Aspen Laser

Introduction: A New Horizon in Autoimmune Thyroid Disease

Hashimoto thyroiditis (HT) is the most common autoimmune endocrine disorder in the world—and one of the most frustrating for patients and clinicians alike. Affecting an estimated 14–20 million Americans, Hashimoto’s gradually destroys thyroid tissue through chronic lymphocytic inflammation, oxidative stress, and progressive fibrosis. For decades, the medical community has approached this condition with one main tool: thyroid hormone replacement. While levothyroxine effectively normalizes laboratory values, it does nothing to halt the autoimmune attack, restore thyroid structure, reduce antibody burden, or improve tissue health.

This leaves millions of patients symptomatic and discouraged, even when their labs read as “normal.” Fatigue, brain fog, weight changes, cold intolerance, mood disturbances, and metabolic dysfunction persist in up to 40% of individuals despite appropriate thyroid hormone dosing. The discrepancy between biochemical euthyroidism and ongoing clinical suffering highlights a central truth: Hashimoto’s is not merely a hormone deficiency—it is a progressive autoimmune and tissue disease.

Dr. Angela Mazza, a nationally recognized integrative endocrinologist, believes it is time to elevate thyroid care beyond hormone replacement and into the era of true disease modification. Based on her experience, advanced imaging collaborations, and deep understanding of endocrine immunology, she proposes a bold scientific direction: Photobiomodulation (red and near-infrared light therapy) may be the first realistic, non-pharmacologic therapy capable of modifying the course of Hashimoto thyroiditis at its root.

---

The Science Behind Near Infrared Laser Therapy:

Why Red Light Has a Unique Role in Thyroid Health**

Photobiomodulation (PBMT), including red and near-infrared (NIR) light therapy, uses specific wavelengths (typically 600–1100 nm) to stimulate cellular repair, reduce inflammation, and restore physiologic function. Unlike ablative lasers or heating devices, PBMT works at low power densities, initiating photochemical—not thermal—reactions within cells.

The thyroid gland is uniquely suited to benefit from PBMT for several reasons:

1. High Mitochondrial Density

Thyroid follicular cells are among the most metabolically active cells in the body. PBMT directly stimulates cytochrome c oxidase within mitochondria, leading to:

·   Increased ATP production

·   Enhanced cellular energy metabolism

·   Improved oxygen use

·   Restoration of injured or dysfunctional cells

A gland dependent on mitochondrial-driven hormone synthesis is ideally positioned to respond positively to PBMT.

 

2. Reduction of Oxidative Stress

Hashimoto’s is characterized by heightened oxidative stress—partly because the thyroid uses hydrogen peroxide (H₂O₂) to create hormones, and partly because autoimmune inflammation generates excess reactive oxygen species (ROS).

PBMT has been shown to:

·   Lower ROS production

·   Activate the body’s natural antioxidant enzymes

·   Reduce oxidative injury within thyroid tissue

This helps protect thyroid follicles from continued immune-mediated destruction.

 

3. Immune Modulation

Hashimoto’s involves an overactivation of Th1 and Th17 immune pathways and impaired T-regulatory (Treg) function. PBMT has demonstrated:

·   Downregulation of NF-κB (a major inflammatory switch)

·   Reduction of pro-inflammatory cytokines (IL-6, TNF-α, IL-1β)

·   Increased Treg activity and improved immune tolerance

·   Shift from M1 to M2 macrophages, promoting resolution instead of damage

This is precisely the type of immune correction needed in HT.

 

4. Improved Microcirculation

Lack of microvascular flow contributes to tissue inflammation and impaired healing. PBMT stimulates nitric oxide release and angiogenesis, improving perfusion and allowing nutrients, oxygen, and immune-calming factors to reach damaged tissue.

 

5. Potential Reversal of Fibrosis

Long-standing Hashimoto’s causes fibrosis and architectural distortion visible on ultrasound. PBMT has shown the ability to regulate collagen turnover, reduce fibroblast overactivity, and promote structural recovery—an unprecedented outcome in thyroid disease.

---

 

Evidence Supporting PBMT in Hashimoto’s

Although relatively new in thyroid medicine, PBMT already has promising published evidence:

·  A 2010 pilot study showed improved thyroid echogenicity, reduced antibodies, and measurable improvements on ultrasound.

·  A 2013 randomized, placebo-controlled trial demonstrated improved thyroid function and reduced levothyroxine requirements in a significant portion of treated participants.

·  A 2018 longitudinal study found sustained benefits up to 6 years post-treatment, including improved thyroid architecture and, in some cases, maintained euthyroidism without medication.

·  A 2022 systematic review concluded that PBMT is safe, biologically plausible, and shows consistent signals of benefit—yet emphasized the need for larger, properly designed clinical trials.

While early-stage, these findings support Dr. Mazza’s premise that PBMT may be the first intervention capable of altering the natural history of Hashimoto thyroiditis.

---

Why Current Thyroid Care Is Not Enough

The standard treatment approach—monitoring labs and adjusting medication—fails to address:

·  Ongoing autoimmune destruction

·  Tissue-level inflammation and fibrosis

·  Vascular stagnation

·  Mitochondrial dysfunction

·  Antibody persistence

Adjunctive interventions such as selenium, myo-inositol, dietary changes, or low-dose naltrexone can provide incremental support but do not stop or reverse disease progression. The result is a clinical gap: patients remain symptomatic because the underlying disease remains unaddressed.

PBMT may finally offer a tool to intervene where endocrine medicine has historically been unable to act.

---

Dr. Mazza’s Vision: A Disease-Modifying Future for Thyroid Care

Dr. Mazza proposes a groundbreaking clinical trial that integrates:

·        Red/NIR photobiomodulation

·        High-resolution ultrasound

·        Elastography for fibrosis analysis

·        Vascular Doppler assessment

·        Thyroid antibodies and hormone panels

·        Clinical symptom scoring

This holistic, multimodal assessment merges endocrine science with state-of-the-art imaging to evaluate PBMT’s capacity to restore thyroid health—not just manage symptoms.

Her vision is clear:

“Hashimoto’s has never had a true disease-modifying therapy. Photobiomodulation may be the first treatment capable of changing the trajectory of thyroid autoimmunity.”

This study aims to produce the most comprehensive thyroid PBMT dataset ever generated in the U.S., offering device manufacturers a unique opportunity to align their technology with a potentially revolutionary medical advancement.

---

Advantages for PBMT Developers

Manufacturers stand to gain:

1. Clinical Validation for Expanded Indications

A successful trial supports FDA considerations, clinical claims, and broader adoption.

2. Entry Into a Multi-Million-Patient Market

Thyroid disease affects 1 in 8 women and is one of the most undertreated autoimmune disorders.

3. Differentiation in a Competitive PBMT Industry

Being the first device validated for autoimmune thyroiditis establishes unmatched market leadership.

4. High-Visibility Clinical Exposure

Results will be shared through medical conferences, scientific publications, and national education initiatives.

---

Conclusion: Lighting the Path to a New Standard of Care

Hashimoto thyroiditis has remained a clinical paradox: highly prevalent, deeply impactful, yet medically underserved. Hormone replacement manages symptoms, but does not change the underlying autoimmune disease. With photobiomodulation, Dr. Mazza sees the possibility of a true shift—a therapy that addresses mitochondrial health, inflammation, microcirculation, oxidative stress, and tissue integrity all at once.

This theory is grounded in strong scientific rationale, supported by emerging evidence, and guided by clinical experience. If validated, PBMT could become the first-ever treatment capable of modifying the course of Hashimoto thyroiditis.

For device innovators and PBMT manufacturers, this is not just an opportunity—it is a chance to participate in a transformative movement in thyroid medicine.
The light that photobiomodulation delivers may very well become the light that leads millions of patients to lasting, meaningful healing.

 

 P A R T   2

THE EYE WITHIN UNLOCKING THE HIDDEN LANGUAGE OF MEDICAL IMAGING By: Lennard M. Goetze, Ed.D   In an age when medical imaging technologies grow more advanced by the day, one truth remains unchanged: a scan is only as valuable as the mind interpreting it. The Eye Within pulls back the curtain on the art and science of diagnostic interpretation through the career and insights of Dr. Robert Bard—internationally recognized cancer imaging specialist, educator, and pioneer in ultrasound diagnostics. This is not a book about machines; it is about mastery. Dr. Bard takes readers into the high-stakes environment of medical imaging, where detecting a shadow, reading a flow pattern, or recognizing a subtle shift in tissue texture can change a life. With clarity and precision, he explains how ultrasound—when wielded by an experienced interpreter—becomes more than a tool for capturing anatomy. It becomes a dynamic instrument for understanding disease behavior, predicting progression, and guiding treatment. From evaluating elusive thyroid disorders to identifying aggressive cancers others might miss, Dr. Bard demonstrates the power of seeing beyond the image. His work exemplifies how structural detail, physiologic clues, and contextual patient information combine into a complete diagnostic picture. At its heart, The Eye Within is both an education and a call to action—urging the medical community to value interpretation as a central pillar of care. For clinicians, students, and health advocates, it is a masterclass in precision medicine. For patients, it is reassurance that in the right hands, every image tells a story—and the right interpreter knows exactly how to read it.    Copyright © 2025- Hummingbird Medical Press / Lennard Goetze Publications. All rights reserved.

READING BETWEEN THE ECHOES

Dr. Bard Reviews Dr. Mazza's Thyroid Ultrasound Scans

 

Introduction – The Eye That Reads Beyond the Image

In the evolving landscape of diagnostic imaging, technology has made breathtaking advances. Yet, as Dr. Robert Bard often reminds all his colleagues, “It’s not the probe, but the interpreter, that saves the patient.”

Ultrasound has become a preferred frontline tool for thyroid evaluation, particularly for identifying nodules, monitoring autoimmune conditions like Hashimoto’s disease, and managing hyperactive disorders such as Graves disease. But while many can operate the machine, very few can translate its subtle, often cryptic language into decisive clinical insight. Dr. Bard is one of those few—a master “ultrasound translator” who sees patterns, behaviors, and evolving risks invisible to most.

This observational session—built on a series of ten thyroid ultrasound slides provided by Dr. Angela Mazza—offers a rare glimpse into the process of real-time interpretation. Six images focus on thyroid nodules; the remaining highlight hallmark features of Hashimoto’s thyroiditis and Graves disease. As Dr. Bard examines each slide, he performs not merely an identification exercise, but an on-time analysis: assessing the surrounding anatomy, interpreting vascular and tissue signatures, and predicting potential outcomes.

Even in an era of AI-assisted imaging, this skill remains irreplaceable. Artificial intelligence can catalog shapes and colors, but it cannot yet replicate the human ability to weigh anatomical nuance, integrate patient history, evaluate the tumor’s ecosystem, and make forward-looking predictions. Interpretation—true interpretation—blends technology, clinical reasoning, and physiological understanding.

---

Dr. Angela Mazza introduces her scans of a patient, touring us into the THYROIDSCAN process. Below are are Dr. Bard’s own notes, presented in the first person, refined for clarity and depth, reflecting his approach as both a diagnostician and educator.

Assessment 1: NODULES

 

Click to enlarge

Solid Growth Without Suspicious Calcifications

I begin with the skin layer clearly visible at the top, followed by the anterior neck musculature and, deeper, the thyroid itself. The lesion’s borders are smooth—always a favorable sign—and I see no suspicious microcalcifications. While microcalcifications are nonspecific, their presence can indicate tissue degeneration from rapid tumor growth and poor vascular supply. Here, the echo pattern is heterogeneous, meaning the texture varies within the nodule, which warrants closer review. Of particular academic interest is the posterior wall brightness—dimmer than the anterior—reflecting sound absorption by solid tissue. This “through transmission” loss can signal dense or heterogeneous pathology and is an important interpretive clue.

 

Click to enlarge

Simple Cyst with High Through Transmission

This image shows a well-circumscribed, cystic structure. The posterior border is brighter than the anterior because fluid allows sound to pass freely. Internal debris is visible—common in benign cysts and observable with high-resolution probes. Surrounding tissues are neither compressed nor invaded, suggesting no aggressive behavior. This is a prime example of strong through transmission, a useful differentiator between cystic and solid pathology.

Click to enlarge

Partially Cystic Complex Nodule
This lesion exhibits both solid and cystic components, the most common benign thyroid pattern but also possible in malignancies. The posterior border is again brighter due to the fluid component. On the left, I note the common carotid artery—its wall smooth and without plaque. When scanning thyroids, I always evaluate adjacent structures; lymph nodes and vessels often provide indirect clues to pathology.

Click to enlarge

Predominantly Solid Complex Nodule with Early Calcification

Here, the anterior and posterior borders are similar in brightness, suggesting limited fluid content. The heterogeneous echo texture and a small calcification at the cystic-solid interface may represent tumor degeneration. It’s important to remember that tumor enlargement during therapy does not always indicate progression—degenerating tumors can swell with fluid before shrinking.

 

 

Click to enlarge

Septated Complex Nodule with Macrocalcification

The lesion contains cystic and solid areas separated by septations, giving it a spongiform appearance. The macrocalcification is consistent with degenerative change. The bright posterior border confirms significant cystic degeneration—what I refer to as “internal cystic necrosis”—often a sign of tumor breakdown.

 

Assessment #2:  THYROID CANCER    

 

Click to enlarge

Classic Ultrasound Signatures of Thyroid Cancer

In this case, credit must be given to Dr. Angela Mazza for her precise capture of a lesion demonstrating classic hallmarks of thyroid cancer. High-quality image acquisition is not accidental—it reflects an operator’s ability to optimize probe selection, angulation, and focal depth to reveal the lesion’s most telling features. This provides the interpreting radiologist with the complete visual data needed for an accurate assessment. One such feature is the presence of microcalcifications—tiny, punctate echogenic foci within the lesion. While not exclusively diagnostic of cancer, their occurrence often signals abnormal cellular turnover and tissue degeneration, making them an important red flag in the radiologist’s assessment.

A second hallmark is the firm, rigid texture of malignant tissue. I often describe it to students using the “steel analogy”: just as steel resists penetration, cancerous tissue offers a gritty, unyielding resistance to a biopsy needle. This hardness correlates with the tumor’s dense cellular structure and fibrotic reaction. Equally significant is the taller-than-wide dimension ratio. Benign nodules, when they grow, tend to expand laterally, developing smooth, encapsulated borders. Aggressive cancers, however, often invade vertically, crossing tissue planes. This vertical dominance is a subtle but critical diagnostic cue—used not only in thyroid cancer but also in breast oncology.

On ultrasound, malignancies typically appear hypoechoic—darker than the surrounding thyroid parenchyma—because the dense cellular mass absorbs more sound energy, allowing less to be reflected back to the transducer. This also results in a posterior acoustic shadow or a dimmer back border, further reinforcing the suspicion of a solid, infiltrative process. When these elements—microcalcifications, firmness, hypoechogenicity, vertical growth, and diminished posterior transmission—are observed together, they form a constellation of findings that strongly favor malignancy. The role of the interpreting radiologist is not simply t note these features, but to integrate them into a complete risk profile for each patient, guiding both urgency and strategy in clinical management.

 

Assessment 3: HASHIMOTO’S & GRAVES DISEASE

 

Click to enlarge

Hashimoto’s Thyroiditis

Hashimoto’s presents variably on ultrasound—sometimes uniform in echotexture, sometimes showing fibrotic stranding and mixed internal patterns. Routine thyroid blood panels can miss autoimmune-mediated inflammation, making ultrasound a critical adjunct. The gland may reveal fibrotic bands, patchy echogenic change, or small cystic areas depending on the stage of degeneration. In this case, the echo pattern is mixed, with no significant change in rear-wall brightness compared to normal thyroid tissue. Because through-transmission may remain unaltered, interpretation must be integrated with autoimmune-specific serology, patient symptoms, and disease history to achieve a confident diagnosis and guide long-term management.

 

 

Graves

Click to enlarge

Disease: Baseline B-Mode & with Color Doppler

Although Graves’ disease is not a form of cancer, it remains a significant thyroid condition because of its system-wide effects and marked increase in glandular blood flow. The overproduction of thyroid hormones accelerates metabolism across multiple organ systems, influencing cardiovascular function, skin changes, and general physiological balance. In grayscale (B-mode) ultrasound, the thyroid often presents with a uniform appearance, though areas of patchy irregularity from fibrotic change may be visible. Through-transmission typically mirrors that of normal tissue; however, the clearest diagnostic distinction emerges when color Doppler imaging is applied.

 

Under Doppler, Graves’ disease can display a pronounced surge in intrathyroidal vascularity, with smooth, branching blood vessels feeding an overactive gland. This striking visual signature—sometimes described as a “thyroid inferno”—serves not only as an identifier of disease activity but also as a guide for therapy. By following these vascular patterns over time, clinicians can fine-tune treatment plans and adjust dosages without invasive biopsies or radioactive scans.

 

 

THERMOLOGY: THE STRATEGIC FIRST STEP IN THYROID IMAGING

Before an ultrasound probe touches the skin, thermographic imaging can create a dynamic map of the thyroid’s physiologic activity. By detecting infrared heat patterns from the skin surface, thermology reveals areas of abnormal vascular activity—whether from inflammation, autoimmune flare, or tumor-driven angiogenesis. This non-contact, radiation-free technique serves as an early “scout,” directing the sonographer’s focus to regions most likely to harbor disease.

 

When paired with ultrasound, thermology’s surface heat mapping complements sonography’s deeper structural view. Elevated heat zones may correspond to hypervascular nodules in Graves’ disease or inflammatory patterns in Hashimoto’s, while cooler areas may signal cystic or fibrotic changes. Beyond detection, thermal assessment can monitor treatment response—declines in both vascularity and gland temperature often indicate therapy is working. 

In skilled hands, this dual-modality approach—thermology for physiologic mapping and ultrasound for structural definition—offers a fast, noninvasive, and highly precise pathway for diagnosis, monitoring, and personalized thyroid care.

 

CONCLUSION – A PARTNERSHIP IN PRECISION

Dr. Bard’s review of Dr. Angela Mazza’s thyroid ultrasound cases demonstrates why expertise in interpretation remains indispensable. Every scan is more than an image—it is a layered narrative of structure, function, and evolving physiology. By coupling her deep endocrinology expertise with ultrasound as a primary diagnostic tool, Dr. Mazza ensures her patients receive assessments that are both scientifically rigorous and dynamically responsive.

In an age where algorithms threaten to overshadow human judgment, this collaboration underscores an enduring truth: the best outcomes emerge when skilled imaging interpretation meets the informed clinical context of a specialist who understands the whole patient.

 

 COPYRIGHT NOTICE

This article draft is an original work produced by the writing and editorial team of the AngioInstitute (a 501(c)(3) nonprofit organization), created exclusively for use, distribution, and publication by DetoxScan.org. All content contained herein, including written material, concepts, titles, and formatting, is the intellectual property of the AngioInstitute and is protected under United States and international copyright laws. Unauthorized reproduction, copying, distribution, transmission, or republication of any portion of this material—whether in print, digital, or any other format—is strictly prohibited without prior written permission from the copyright holder. The AngioInstitute retains full ownership of the content until and unless formally transferred in writing. This draft may not be altered, adapted, or used in derivative works without express consent. All rights reserved. For inquiries regarding usage, permissions, or content licensing, please contact the AngioInstitute directly.

From Crisis to Calling: Russ Allen’s Battle with Obesity and His Mission to Save Lives

 By: Lennard M. Goetze, Ed.D / Charlene Rejichian, Ph.D

Introduction: A Life on the Line
Russ Allen’s story is more than just about losing weight—it is about saving a life. After enduring five heart attacks, multiple strokes, cancer, and years of living with obesity-related illness, Russ didn’t just turn his life around—he created a movement to help others do the same. From standing on the floor of the New York Stock Exchange with NFL alumni to lying on an operating table after emergency bypass surgery, his journey is a powerful testimony of transformation, resilience, and purpose.

A History Written in Heart Attacks
Russ’s wake-up call came later in life, at age 55, when he suffered his first coronary event. He had already received two cardiac stents by then, but that was just the beginning of a dangerous cascade. By the time he underwent a quadruple bypass, Russ had survived five heart attacks, three ablations, and multiple hospitalizations. At one point, he even had a stroke—brought on, in part, by poor lifestyle choices and stress—after celebrating a friend’s 70th birthday with wine.

During one of the most alarming episodes, he drove himself to the hospital in the middle of having a stroke. “That kinda flipped them out,” he recalls. Remarkably, thanks to timely administration of Eliquis and immediate care, he recovered quickly. But the lesson stuck. Russ realized that everything he was experiencing—heart disease, stroke, and even prostate cancer—was the direct result of a lifetime struggling with obesity.

Turning Pain into Purpose
At his peak weight of 238 pounds, Russ knew something had to change. Using a medically supervised meal replacement program, he dropped to 193 pounds. But beyond the number on the scale, what changed was his mission.

Russ became the Director of Wellness for the NFL Alumni Association, overseeing a wellness program that, under a Novo Nordisk grant, helped former athletes lose weight. “The average guy lost 35 pounds,” he notes, “and about 50% of them kept it off.” This work grew into a broader campaign: Tackle Obesity, which has since been recognized by the city of New York with an official “Tackle Obesity Day” and celebrated by NFL icons like Otis Anderson, MVP of Super Bowl XXV.

Russ’s message is personal and profound: “Cancer, heart disease, and stroke are all resulting from my obesity. So now, I’ve committed my life to helping others avoid what I went through.”

The Science and Simplicity of Prevention
Russ is a strong believer in preventive healthcare, and he’s especially passionate about the power of ultrasound imaging as a non-invasive tool for identifying early risks associated with obesity—such as arterial blockage, fatty liver disease, and organ inflammation. He praises ultrasound as “the best screening solution out there,” citing its affordability, accessibility, and safety compared to more invasive diagnostics.

His passion also extends to red light therapy, a modality he incorporates into his practice at Optimal Wellness. He uses it for core strengthening, inflammation reduction, and improving sleep—benefits he’s seen firsthand in himself, his wife, and his clients.

Lifestyle Overhaul: Movement, Mindset, and Marriage
Once sedentary, Russ now embraces movement as medicine. He gave up golf—not active enough—and took up biking and rowing, often alongside his wife Kay. “We do things together now,” he says, emphasizing that sustainable change requires partnership and enjoyment.

His home routine includes strength training with resistance bands and a rowing machine, all part of a holistic plan to maintain his heart health and avoid relapse. More importantly, Russ reflects on the emotional drivers behind his earlier weight gain: chronic stress, poor food choices, and ignorance about the true impact of lifestyle on health.

“High-carb, high-calorie foods, stress, and cortisol—it’s a deadly combo,” he admits. “I had the disease because of my lifestyle.”

Obesity as a Silent Killer
Perhaps the most chilling part of Russ’s story is how normal his previous life had seemed—until it nearly killed him. From the outside, he was a successful businessman, a leader in wellness, and a public advocate. Inside, his body was deteriorating. As he puts it, “I’ve had prostate cancer, five heart attacks, a stroke… all of which trail back to my obesity.”

He’s quick to challenge the reliance on pharmaceutical fixes, pointing out that while drugs like GLP-1s have their place, they should not replace lifestyle change. “The more an individual can achieve their goals without pharmaceutical agents, the better,” he insists.

Tackling the Stigma, Broadening the Message
Through his companies Wellness Now and Optimal Wellness, Russ continues to spread his message. He sees educational materials, animations, posters, and clinical tools like ultrasound as essential in reaching the public—especially those who don’t realize how closely tied obesity is to life-threatening diseases.

He also calls out the hypocrisy and profit motives within certain health organizations, noting how large percentages of their funding come from pharmaceutical companies with little real incentive to “cure” chronic conditions like diabetes or obesity.

Still, Russ focuses on hope. “The best news I got from my surgeon was: ‘You now have the same life expectancy as someone who never had the disease. So go home and die of something else.’ That was great!”

Lessons Learned: Obesity Is Treatable, Life Is Worth Saving
Russ Allen’s journey teaches us that obesity isn’t a cosmetic issue—it’s a chronic disease with deadly consequences. But it is treatable, and prevention is possible. His story underscores the importance of regular screenings, holistic health strategies, and emotional support systems.

Key Takeaways:

·        Obesity is a gateway to cancer, heart disease, and stroke.

·        Lifestyle—not luck—is the deciding factor in most health outcomes.

·        Prevention tools like ultrasound and red light therapy can help people detect risks early and take meaningful action.

·        Community and accountability, like Russ’s work with the NFL alumni, significantly improve the chances of sustainable weight loss.

·        Living well is a choice. Russ’s transformation was not accidental—it was deliberate, disciplined, and driven by love for life.

As Russ puts it, “There’s nothing better to do to prevent cancer than to get control of your weight.” From the edge of death to a beacon of hope, Russ Allen's story is a reminder that even the deepest health setbacks can spark the greatest comebacks.

----------------------------------------------------------------------------------------------------------------------

AFTERTHOUGHT
By Dr. Robert L. Bard

Diagnostic Imaging Specialist, Wellness Advocate

Russ Allen’s story isn’t just a personal journey—it’s a mirror held up to the medical community. As someone who has spent decades using imaging technologies to detect disease, I’ve seen firsthand what chronic illness looks like from the inside out: blocked arteries, enlarged hearts, fatty livers. I’ve watched what obesity does to the body. But Russ brings this reality to life in a way a scan never could—by showing what happens when you reverse the damage.

Three open-heart surgeries, a stroke, and prostate cancer would be enough to make most people give up. Instead, Russ made the decision to fight back. He didn’t just lose over 100 pounds—he reclaimed his life and created a program to help others do the same.

What strikes me most is his clarity on the why. Weight loss wasn’t cosmetic. It was survival. It was legacy. It was proof that wellness begins with ownership.

From my perspective as a diagnostic specialist, stories like Russ’ validate the importance of prevention and early intervention. His life reinforces what I try to teach my patients every day: real change begins with seeing the truth—whether through imaging or self-reflection.

Russ is now a living testimonial, not just of transformation, but of accountability in action. He’s not selling a miracle; he’s offering a roadmap—one that could save countless lives.

And for that, I applaud him.

 

Ultrasound Imaging: A Vital Approach to Detecting Obesity-Linked Health Disorders

By: Lennard Goetze, Ed.D / Edited by: Robert Bard, MD 

Introduction

Obesity is a long-term health condition impacting more than a billion people worldwide, with numbers rising steadily due to modern dietary patterns, low physical activity, genetics, and environmental influences. Beyond visible weight gain, obesity disrupts nearly every organ system, triggering widespread complications that shorten lifespan and degrade quality of life. These include cardiovascular problems, type 2 diabetes, liver damage, hormonal and neurological disturbances, certain cancers, and musculoskeletal disorders.

While traditional diagnostic approaches often involve invasive procedures or costly imaging scans, ultrasound technology has become an essential, safe, and highly adaptable method for evaluating obesity-related diseases. The poster provided illustrates how ultrasound can scan multiple organ systems affected by excess weight, supporting early detection, risk evaluation, and targeted treatment planning.

HOW OBESITY IMPACTS ORGAN SYSTEMS

Obesity is not confined to fat accumulation beneath the skin. It causes hormonal imbalance, inflammation, and structural strain that interfere with normal organ function. Key systems affected include:

 1. Cardiovascular Health
Obesity places a heavy burden on the heart and vascular system, significantly increasing the risk for a range of cardiovascular disorders. One of the most common consequences is atherosclerosis, a condition where fat, cholesterol, and plaque build up inside the arterial walls, narrowing the vessels and restricting blood flow. This can lead to serious complications such as coronary artery disease, angina, heart attacks, and congestive heart failure. The excess body mass also increases blood volume, causing the heart to work harder to pump blood throughout the body, eventually weakening the heart muscle over time.

Another major concern is hypertension, or high blood pressure, which becomes more prevalent as body mass index (BMI) rises. Persistent high pressure within the arteries damages vessel linings, accelerates plaque formation, and increases the risk of stroke, kidney disease, and heart failure. Obesity also disrupts lipid metabolism, leading to dyslipidemia—a condition marked by elevated LDL (“bad” cholesterol), high triglycerides, and reduced HDL (“good” cholesterol), all of which further strain cardiovascular health.

Doppler ultrasound provides a powerful, non-invasive way to assess these risks in real time. It allows physicians to visualize blood flow through arteries and veins, detect vascular narrowing or blockages, identify deep vein thrombosis (DVT) or arterial plaques, and evaluate heart valve function and cardiac output. This radiation-free method enables early diagnosis of potentially life-threatening cardiac conditions and helps tailor preventive or therapeutic strategies for patients at risk due to obesity.

2. Liver Function

Carrying excess weight is a leading factor in nonalcoholic fatty liver disease (NAFLD), where fat deposits accumulate in liver cells. This may advance to:

· Steatohepatitis: Inflammation damaging liver tissue.

· Cirrhosis: Permanent scarring impairing the organ’s ability to function.

Advanced ultrasound elastography measures tissue stiffness and identifies inflammation, enabling early management before irreversible liver damage occurs.

3. Pancreatic Health

Obesity is strongly linked to pancreatic inflammation and impaired insulin regulation, paving the way for type 2 diabetes. Chronic pancreatitis damages digestion and increases risk for further complications. Ultrasound offers a real-time, painless look at pancreatic swelling, structural abnormalities, or tissue injury, guiding timely treatment.

 

4. Gallbladder Disorders

Excess weight changes cholesterol processing, causing gallstones and other gallbladder conditions that lead to pain, infections, and bile duct blockages. Ultrasound remains the primary diagnostic tool for gallbladder imaging, spotting stones, bile buildup, or abnormal thickening quickly and accurately.

 

5. Brain and Neurological Function

Obesity can increase intracranial pressure, resulting in headaches, vision disturbances, and, in severe cases, elevated stroke risk. Transcranial Doppler ultrasound provides a non-invasive way to track blood flow to the brain, identifying circulation problems and reducing neurological complication risks early on.

 

6. Thyroid and Hormonal Balance

Obesity frequently disrupts endocrine function, contributing to:

               · Thyroid disorders: Reduced thyroid activity slows metabolism, complicating weight loss.

               · Metabolic syndromes: Insulin resistance and hormone imbalances create a cycle of fat storage                               and inflammation.

               ·  Polycystic ovarian syndrome (PCOS): Common in overweight women, affecting fertility and                menstrual cycles.

Specialized ThyroidScan ultrasound evaluates gland size, nodules, and vascular activity, giving doctors clear insight into thyroid-related dysfunction.

7. Reproductive Health

Excess body fat impacts reproductive organs:

               ·  In women: It often causes irregular menstruation, infertility, and ovarian cyst development.

               ·  In men: Hormonal shifts reduce testosterone levels, affecting fertility and increasing prostate problems.

Transvaginal and transrectal ultrasound provides detailed imaging of reproductive structures, detecting abnormalities early and aiding fertility care.

8. Cancers Associated with Obesity

Numerous cancers have documented links to excess weight, including:

        ·  Breast                    ·  Uterus

        ·  Cervix                    ·  Colon

        ·  Esophagus             ·  Pancreas

        ·  Kidney                   ·  Prostate

Ultrasound plays a crucial role in screening suspicious growths, guiding biopsies, and monitoring tumors over time, enabling prompt treatment decisions.

9. Musculoskeletal Stress

Excess body weight places continuous mechanical strain on bones, joints, and surrounding connective tissues, which significantly accelerates the onset and progression of osteoarthritis. This degenerative joint condition leads to chronic pain, stiffness, inflammation, and limited range of motion—especially in weight-bearing joints such as the knees, hips, and lower back. The pressure from obesity contributes not only to physical wear-and-tear but also to a systemic inflammatory state that worsens joint degeneration over time. In addition, obesity raises the risk of gout, a painful inflammatory arthritis caused by elevated uric acid levels that crystallize in the joints, most commonly affecting the big toe, ankles, and knees. These crystal deposits can trigger sudden, severe attacks of joint pain, redness, and swelling.

Musculoskeletal ultrasound has become a highly valuable diagnostic tool in evaluating these conditions. It enables clinicians to visualize soft tissue structures in real time, identifying signs of joint effusion (fluid buildup), synovitis (inflammation of the joint lining), bursitis, and even early cartilage degradation. Unlike X-rays, which mainly show bone changes, ultrasound can detect subtle soft tissue inflammation and differentiate between mechanical and inflammatory pain sources.

Ultrasound can also guide joint aspiration or corticosteroid injections with high precision, ensuring that therapeutic agents are delivered exactly where needed. Furthermore, repeated scans allow physicians to monitor disease progression and response to treatment non-invasively. For patients with limited mobility or chronic pain, the portability and safety of ultrasound make it an ideal imaging solution. Ultimately, ultrasound plays a critical role in the early diagnosis, monitoring, and personalized management of obesity-related musculoskeletal disorders, improving patient outcomes and quality of life.

 

10. Circulatory and Skin Conditions

Obesity slows blood flow in extremities, leading to phlebitis, venous stasis, and chronic swelling. These vascular issues can lead to dangerous clots and skin ulcers.  Ultrasound provides a non-invasive way to trace blood clots, assess venous health, and identify early warning signs of poor circulation before complications develop.

Alternate feature story

WHY ULTRASOUND IS KEY IN OBESITY DIAGNOSTICS

The poster emphasizes ultrasound’s versatility in examining obesity-related diseases. Its advantages include:

·        Completely non-invasive: No radiation exposure or surgical entry needed.

·        Instant results: Physicians can see organ conditions live during the scan.

·        Multi-organ reach: A single technology evaluates the heart, liver, thyroid, pancreas, reproductive system, joints, and blood vessels.

·        Affordable and accessible: Less costly than CT or MRI, widely available worldwide.

By integrating ultrasound into obesity management, healthcare providers can identify hidden organ stress, detect disease early, and create personalized treatment plans before conditions reach a critical stage.

 

Conclusion

Obesity is far more than a cosmetic concern—it is a multi-organ health crisis with far-reaching consequences. It fuels cardiovascular disease, liver dysfunction, diabetes, hormone imbalances, reproductive issues, cancers, neurological complications, and musculoskeletal deterioration.

Ultrasound imaging is an indispensable diagnostic ally, offering a fast, safe, and cost-effective window into obesity’s hidden impact on the body. With advancements like Doppler technology and elastography, clinicians can visualize organ damage, measure tissue health, and track blood flow—all without invasive procedures or harmful radiation.

Given the ongoing obesity epidemic worldwide, widespread use of ultrasound for early screening and disease monitoring should become a standard of care. It empowers doctors to intervene earlier, improve outcomes, and help patients reclaim their long-term health before obesity-related conditions become life-threatening.

ROBERT L. BARD, MD, PC, DABR, FASLMS - Advanced Imaging & Diagnostic Specialist
Having paved the way for the study of various cancers both clinically and academically, Dr. Robert Bard co-founded the 9/11 CancerScan program to bring additional diagnostic support to all first responders from Ground Zero. His main practice in midtown, NYC (Bard Diagnostic Imaging- www.CancerScan.com) uses the latest in digital Imaging technology has been also used to help guide biopsies and in many cases, even replicate much of the same reports of a clinical invasive biopsy. Imaging solutions such as high-powered Sonograms, Spectral Doppler, sonofluoroscopy, 3D/4D Image Reconstruction and the Spectral Doppler are safe, noninvasive, and does not use ionizing radiation. It is used as a complement to find anomalies and help diagnose the causes of pain, swelling and infection in the body’s internal organs while allowing the diagnostician the ability to zoom and ‘travel’ deep into the body for maximum exploration.

 ----------------------------------------------------------------------------------------------------------------------------

BEYOND THE SCALE: An Endocrinologist’s Deep Dive into the Modern Weight Loss Battle

A Professional Analysis by: Dr. Angela Mazza

Obesity is one of the most pressing health challenges of our time, with rates projected to affect nearly half of the U.S. population by 2030. Despite endless diet trends, a booming pharmaceutical market, and a culture obsessed with quick fixes, sustainable weight loss remains elusive for millions. According to Dr. Angela Mazza, an integrative endocrinologist specializing in hormonal health and metabolic disorders, the weight loss struggle is far more complex than calories in versus calories out—it is a multi-layered challenge rooted in hormones, inflammation, lifestyle, and a medical environment that often prioritizes shortcuts over solutions.

Obesity: The Complex, Hormone-Driven Condition

Dr. Mazza sees patients every day who have tried everything—diets, supplements, exercise regimens—yet remain stuck in cycles of weight gain and frustration. Many come to her with thyroid disorders, prediabetes, type 2 diabetes, polycystic ovary syndrome (PCOS), low testosterone, or are navigating perimenopause and menopause. Despite medical interventions to balance thyroid hormones, regulate estrogen or progesterone, or restore testosterone levels, weight loss often remains stubbornly out of reach.

“Obesity isn’t just a lifestyle issue,” Dr. Mazza explains. “It’s a metabolic condition that disrupts how the body processes energy and stores fat. Underneath it, you’ll often find insulin resistance, inflammation, and disrupted hormonal signals that make it incredibly hard for patients to shed weight, even when they’re doing everything ‘right.’” This creates a self-perpetuating cycle: excess fat tissue itself acts as an endocrine organ, releasing hormones and inflammatory compounds that worsen insulin resistance and trigger further fat storage. Over time, this contributes to other serious health conditions such as cardiovascular disease, stroke, and certain cancers.

* See complete feature at THE ROAD TO LONGEVITY

----------------------------------------------------------------------------------------------------------------------------

Disclaimer & Copyright Notice: The materials provided on this website are copyrighted and the intellectual property of the publishers/producers (The NY Cancer Resource Alliance/IntermediaWorx inc. and Bard Diagnostic Research & Educational Programs). It is provided publicly strictly for informational purposes within non-commercial use and not for purposes of resale, distribution, public display or performance. Unless otherwise indicated on this web based page, sharing, re-posting, re-publishing of this work is strictly prohibited without due permission from the publishers.  Also, certain content may be licensed from third-parties. The licenses for some of this Content may contain additional terms. When such Content licenses contain additional terms, we will make these terms available to you on those pages (which his incorporated herein by reference).The publishers/producers of this site and its contents such as videos, graphics, text, and other materials published are not intended to be a substitute for professional medical advice, diagnosis, or treatment. For any questions you may have regarding a medical condition, please always seek the advice of your physician or a qualified health provider. Do not postpone or disregard any professional medical advice over something you may have seen or read on this website. If you think you may have a medical emergency, call your doctor or 9-1-1 immediately.  This website does not support, endorse or recommend any specific products, tests, physicians, procedures, treatment opinions or other information that may be mentioned on this site. Referencing any content or information seen or published in this website or shared by other visitors of this website is solely at your own risk. The publishers/producers of this Internet web site reserves the right, at its sole discretion, to modify, disable access to, or discontinue, temporarily or permanently, all or any part of this Internet web site or any information contained thereon without liability or notice to you.